Long-term Outcomes in Individuals with Prolonged PR Interval or First-degree Atrioventricular Block

Overview

Journal JAMA

Publisher American Medical Association

Specialty General Medicine

Date 2009 Jun 25

PMID 19549974

Citations 210

Authors

Susan Cheng

Michelle J Keyes

Martin G Larson

Elizabeth L McCabe

Christopher Newton-Cheh

Daniel Levy

Emelia J Benjamin

Ramachandran S Vasan

Thomas J Wang

Affiliations

Soon will be listed here.

Abstract

Context: Prolongation of the electrocardiographic PR interval, known as first-degree atrioventricular block when the PR interval exceeds 200 milliseconds, is frequently encountered in clinical practice.

Objective: To determine the clinical significance of PR prolongation in ambulatory individuals.

Design, Setting, And Participants: Prospective, community-based cohort including 7575 individuals from the Framingham Heart Study (mean age, 47 years; 54% women) who underwent routine 12-lead electrocardiography. The study cohort underwent prospective follow-up through 2007 from baseline examinations in 1968-1974. Multivariable-adjusted Cox proportional hazards models were used to examine the associations of PR interval with the incidence of arrhythmic events and death.

Main Outcome Measures: Incident atrial fibrillation (AF), pacemaker implantation, and all-cause mortality.

Results: During follow-up, 481 participants developed AF, 124 required pacemaker implantation, and 1739 died. At the baseline examination, 124 individuals had PR intervals longer than 200 milliseconds. For those with PR intervals longer than 200 milliseconds compared with those with PR intervals of 200 milliseconds or shorter, incidence rates per 10 000 person-years were 140 (95% confidence interval [CI], 95-208) vs 36 (95% CI, 32-39) for AF, 59 (95% CI, 40-87) vs 6 (95% CI, 5-7) for pacemaker implantation, and 334 (95% CI, 260-428) vs 129 (95% CI, 123-135) for all-cause mortality. Corresponding absolute risk increases were 1.04% (AF), 0.53% (pacemaker implantation), and 2.05% (all-cause mortality) per year. In multivariable analyses, each 20-millisecond increment in PR was associated with an adjusted hazard ratio (HR) of 1.11 (95% CI, 1.02-1.22; P = .02) for AF, 1.22 (95% CI, 1.14-1.30; P < .001) for pacemaker implantation, and 1.08 (95% CI, 1.02-1.13; P = .005) for all-cause mortality. Individuals with first-degree atrioventricular block had a 2-fold adjusted risk of AF (HR, 2.06; 95% CI, 1.36-3.12; P < .001), 3-fold adjusted risk of pacemaker implantation (HR, 2.89; 95% CI, 1.83-4.57; P < .001), and 1.4-fold adjusted risk of all-cause mortality (HR, 1.44, 95% CI, 1.09-1.91; P = .01).

Conclusion: Prolongation of the PR interval is associated with increased risks of AF, pacemaker implantation, and all-cause mortality.

Citing Articles

[An atrial fibrillation prediction model based on quantitative features of electrocardiogram during sinus rhythm in the Chinese population].

Zhu X, Shi Y, Shen J, Wang Q, Song T, Xiu J Nan Fang Yi Ke Da Xue Xue Bao. 2025; 45(2):223-228.

PMID: 40031965 PMC: 11875849. DOI: 10.12122/j.issn.1673-4254.2025.02.02.

Excessively prolonged PR interval in a patient with worsening shortness of breath: a case report.

Zhang Y, Jiang Z, Li M BMC Cardiovasc Disord. 2025; 25(1):106.

PMID: 39962398 PMC: 11831768. DOI: 10.1186/s12872-025-04512-2.

Cardiac Conduction Delay for Sodium Channel Antagonist Antiseizure Medications: An Analysis of the Canadian Longitudinal Study on Aging.

Shlobin N, Li J, Sander J, Keezer M, Thijs R Neurology. 2025; 104(4):e210302.

PMID: 39899787 PMC: 11793923. DOI: 10.1212/WNL.0000000000210302.

Blood Pressure Control and Incident Left-Ventricular Conduction Disease.

Frimodt-Moller E, Marcus G Curr Cardiol Rep. 2025; 27(1):29.

PMID: 39831954 DOI: 10.1007/s11886-025-02196-w.

Complete Heart Block in a Patient Declining Pacemaker Implantation: A Discussion on Patient-Centered Care and Shared Decision-Making.

Buntyn R, Patel V, Lewis H, Aung T, Mukerji V Cureus. 2025; 16(12):e75241.

PMID: 39776725 PMC: 11703641. DOI: 10.7759/cureus.75241.

References

Kannel W, Feinleib M, MCNAMARA P, Garrison R, CASTELLI W . An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol. 1979; 110(3):281-90. DOI: 10.1093/oxfordjournals.aje.a112813. View

PACKARD J, GRAETTINGER J, GRAYBIEL A . Analysis of the electrocardiograms obtained from 1000 young healthy aviators; ten year follow-up. Circulation. 1954; 10(3):384-400. DOI: 10.1161/01.cir.10.3.384. View

Darbar D, Jahangir A, Hammill S, Gersh B . P wave signal-averaged electrocardiography to identify risk for atrial fibrillation. Pacing Clin Electrophysiol. 2002; 25(10):1447-53. DOI: 10.1046/j.1460-9592.2002.01447.x. View

PERLMAN L, Ostrander Jr L, Keller J, Chiang B . An epidemiologic study of first degree atrioventricular block in Tecumseh, Michigan. Chest. 1971; 59(1):40-6. DOI: 10.1378/chest.59.1.40. View

Dilaveris P, Gialafos E, Sideris S, Theopistou A, Andrikopoulos G, Kyriakidis M . Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998; 135(5 Pt 1):733-8. DOI: 10.1016/s0002-8703(98)70030-4. View

Fleg J, Das D, Wright J, Lakatta E . Age-associated changes in the components of atrioventricular conduction in apparently healthy volunteers. J Gerontol. 1990; 45(3):M95-100. DOI: 10.1093/geronj/45.3.m95. View

Benjamin E, Levy D, Vaziri S, DAgostino R, Belanger A, Wolf P . Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994; 271(11):840-4. View

Leier C, Meacham J, Schaal S . Prolonged atrial conduction. A major predisposing factor for the development of atrial flutter. Circulation. 1978; 57(2):213-6. DOI: 10.1161/01.cir.57.2.213. View

Mason J, Ramseth D, Chanter D, Moon T, Goodman D, Mendzelevski B . Electrocardiographic reference ranges derived from 79,743 ambulatory subjects. J Electrocardiol. 2007; 40(3):228-34. DOI: 10.1016/j.jelectrocard.2006.09.003. View

10.

Bjornstad H, Bjornstad T, Urheim S, Hoff P, Smith G, Maron B . Long-term assessment of electrocardiographic and echocardiographic findings in Norwegian elite endurance athletes. Cardiology. 2008; 112(3):234-41. DOI: 10.1159/000151435. View

11.

Wang T, Larson M, Levy D, Benjamin E, Leip E, Omland T . Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004; 350(7):655-63. DOI: 10.1056/NEJMoa031994. View

12.

Schnabel R, Sullivan L, Levy D, Pencina M, Massaro J, DAgostino Sr R . Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009; 373(9665):739-45. PMC: 2764235. DOI: 10.1016/S0140-6736(09)60443-8. View

13.

Psaty B, Manolio T, Kuller L, Kronmal R, Cushman M, Fried L . Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997; 96(7):2455-61. DOI: 10.1161/01.cir.96.7.2455. View

14.

DAWBER T, MEADORS G, MOORE Jr F . Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health. 1951; 41(3):279-81. PMC: 1525365. DOI: 10.2105/ajph.41.3.279. View

15.

Yin F, Spurgeon H, Greene H, Lakatta E, WEISFELDT M . Age-associated decrease in heart rate response to isoproterenol in dogs. Mech Ageing Dev. 1979; 10(1-2):17-25. DOI: 10.1016/0047-6374(79)90067-8. View

16.

Erikssen J, Otterstad J . Natural course of a prolonged PR interval and the relation between PR and incidence of coronary heart disease. A 7-year follow-up study of 1832 apparently healthy men aged 40-59 years. Clin Cardiol. 1984; 7(1):6-13. DOI: 10.1002/clc.4960070104. View

17.

Schnittger I, Appleton C, Hatle L, Popp R . Diastolic mitral and tricuspid regurgitation by Doppler echocardiography in patients with atrioventricular block: new insight into the mechanism of atrioventricular valve closure. J Am Coll Cardiol. 1988; 11(1):83-8. DOI: 10.1016/0735-1097(88)90170-2. View

18.

Sweeney M, Hellkamp A, Ellenbogen K, Greenspon A, Freedman R, Lee K . Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003; 107(23):2932-7. DOI: 10.1161/01.CIR.0000072769.17295.B1. View

19.

Agarwal Y, Aronow W, Levy J, Spodick D . Association of interatrial block with development of atrial fibrillation. Am J Cardiol. 2003; 91(7):882. DOI: 10.1016/s0002-9149(03)00027-4. View

20.

Krahn A, Manfreda J, Tate R, Mathewson F, Cuddy T . The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995; 98(5):476-84. DOI: 10.1016/S0002-9343(99)80348-9. View